相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance
Husain Yar Khan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma (vol 77, 633.e1, 2020)
Marie R. Webster et al.
MOLECULAR CELL (2020)
Inhibition of NF-κB-Dependent Signaling Enhances Sensitivity and Overcomes Resistance to BET Inhibition in Uveal Melanoma
Grazia Ambrosini et al.
CANCER RESEARCH (2019)
Targeting the ERK Signaling Pathway in Melanoma
Paola Savoia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Targeting Alterations in the RAF-MEK Pathway
Rona Yaeger et al.
CANCER DISCOVERY (2019)
Diverse Mechanisms of BRAF Inhibitor Resistance in Melanoma Identified in Clinical and Preclinical Studies
Stephen A. Luebker et al.
FRONTIERS IN ONCOLOGY (2019)
Loss of nuclear localization of thyroid transcription factor 1 and adverse outcomes in papillary thyroid cancer
Ana Lopez-Campistrous et al.
HUMAN PATHOLOGY (2019)
JLP-centrosome is essential for the microtubule-mediated nucleocytoplasmic transport induced by extracellular stimuli
Clement M. Lee et al.
SCIENCE ADVANCES (2019)
BRAF Inhibitors in Thyroid Cancer: Clinical Impact, Mechanisms of Resistance and Future Perspectives
Fabiana Crispo et al.
CANCERS (2019)
Molecular Predictors for Advanced Papillary Thyroid Carcinoma Recurrence
Taciana Padilha de Castro et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
Liang Cheng et al.
MODERN PATHOLOGY (2018)
Depletion of nuclear import protein karyopherin alpha 7 (KPNA7) induces mitotic defects and deformation of nuclei in cancer cells
Elisa M. Vuorinen et al.
BMC CANCER (2018)
Karyopherins in cancer
Tolga Cagatay et al.
CURRENT OPINION IN CELL BIOLOGY (2018)
The Rules and Functions of Nucleocytoplasmic Shuttling Proteins
Xuekun Fu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Thyroid hormone receptor localization in target tissues
Cyril S. Anyetei-Anum et al.
JOURNAL OF ENDOCRINOLOGY (2018)
Prognostic Role of BRAFV600E Cellular Localization in Melanoma
Zakaria Y. Abd Elmageed et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2018)
The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib
Hao Song et al.
MEDICAL SCIENCE MONITOR (2018)
Nuclear Export Inhibition for Pancreatic Cancer Therapy
Irfana Muqbil et al.
CANCERS (2018)
HMGB1 represses the anti-cancer activity of sunitinib by governing TP53 autophagic degradation via its nucleus-to-cytoplasm transport
Peihua Luo et al.
AUTOPHAGY (2018)
Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor
Vinod Vijay Subhash et al.
SCIENTIFIC REPORTS (2018)
Controlling the Gatekeeper: Therapeutic Targeting of Nuclear Transport
Friederike K. Kosyna et al.
CELLS (2018)
The Second-Generation Exportin-1 Inhibitor KPT-8602 Demonstrates Potent Activity against Acute Lymphoblastic Leukemia
Thomas Vercruysse et al.
CLINICAL CANCER RESEARCH (2017)
A central role for cadherin signaling in cancer
Antonis Kourtidis et al.
EXPERIMENTAL CELL RESEARCH (2017)
Alterations of the nuclear transport system in hepatocellular carcinoma - New basis for therapeutic strategies
Martin Beck et al.
JOURNAL OF HEPATOLOGY (2017)
KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma
Jonas Cicenas et al.
MEDICAL ONCOLOGY (2017)
PIK3CAH1047R-induced paradoxical ERK activation results in resistance to BRAFV600E specific inhibitors in BRAFV600E PIK3CAH1047R double mutant thyroid tumors
Matthias A. Roelli et al.
ONCOTARGET (2017)
Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer
Wei-Jun Wei et al.
THERANOSTICS (2017)
Metabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets
Domenico Ciavardelli et al.
BIOMED RESEARCH INTERNATIONAL (2017)
BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases
Najla Fakhruddin et al.
SCIENTIFIC REPORTS (2017)
ENDOCRINE TUMOURS Genetic predictors of thyroid cancer outcome
Catarina Tavares et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10-Dependent Apoptosis by Carfilzomib and Selinexor
Shaun Rosebeck et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells
Elyse K. Hanly et al.
ONCOTARGET (2016)
The dynamic subcellular localization of ERK: mechanisms of translocation and role in various organelles
Ehud Wainstein et al.
CURRENT OPINION IN CELL BIOLOGY (2016)
TERT promoter mutations in thyroid cancer
Rengyun Liu et al.
ENDOCRINE-RELATED CANCER (2016)
Recent incidences and differential trends of thyroid cancer in the USA
Yushan Mao et al.
ENDOCRINE-RELATED CANCER (2016)
Targeting nuclear transporters in cancer: Diagnostic, prognostic and therapeutic potential
Tamara Stelma et al.
IUBMB LIFE (2016)
Clinical, Sonographic, and Pathological Characteristics of RAS-Positive Versus BRAF-Positive Thyroid Carcinoma
Sujay Kakarmath et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Vemurafenib in patients with BRAFV600E-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial
Marcia S. Brose et al.
LANCET ONCOLOGY (2016)
Targeting the Nuclear Import Receptor Kpnβ1 as an Anticancer Therapeutic
Pauline J. van der Watt et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Importins and exportins as therapeutic targets in cancer
Amit Mahipal et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Mechanisms of Nuclear Export in Cancer and Resistance to Chemotherapy
Mohamed El-Tanani et al.
CANCERS (2016)
The RanGTP Pathway: From Nucleo-Cytoplasmic Transport to Spindle Assembly and Beyond
Tommaso Cavazza et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
The roles of nucleolin subcellular localization in cancer
Caroline Madeleine Berger et al.
BIOCHIMIE (2015)
The impact of CLAUDIN-1 on follicular thyroid carcinoma aggressiveness
Denise Zwanziger et al.
ENDOCRINE-RELATED CANCER (2015)
Study of PTEN subcellular localization
Angela Bononi et al.
METHODS (2015)
Molecular Pathways Associated with Aggressiveness of Papillary Thyroid Cancer
Salvatore Benvenga et al.
CURRENT GENOMICS (2014)
Nuclear Trafficking in Health and Disease
Amir Mor et al.
CURRENT OPINION IN CELL BIOLOGY (2014)
Nucleo-cytoplasmic transport as a therapeutic target of cancer
Giovanni Luca Gravina et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Selective inhibitors of nuclear export (SINE)- a novel class of anti-cancer agents
Kaushal Parikh et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
CBS9106-Induced CRM1 Degradation Is Mediated by Cullin Ring Ligase Activity and the Neddylation Pathway
Naoya Saito et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
Marcia S. Brose et al.
LANCET (2014)
The myxobacterial metabolite ratjadone A inhibits HIV infection by blocking the Rev/CRM1-mediated nuclear export pathway
Eric Fleta-Soriano et al.
MICROBIAL CELL FACTORIES (2014)
Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents
Joel G. Turner et al.
SEMINARS IN CANCER BIOLOGY (2014)
Clinical translation of nuclear export inhibitors in cancer
William T. Senapedis et al.
SEMINARS IN CANCER BIOLOGY (2014)
Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
Thomas Wiesner et al.
NATURE COMMUNICATIONS (2014)
Promising SINEs for Embargoing Nuclear-Cytoplasmic Export as an Anticancer Strategy
David S. P. Tan et al.
CANCER DISCOVERY (2014)
Targeting nucleocytoplasmic transport in cancer therapy
Richard Hill et al.
ONCOTARGET (2014)
Increased Melanoma Risk in Individuals With Papillary Thyroid Carcinoma
Gretchen M. Oakley et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2014)
CRM1 and BRAF Inhibition Synergize and Induce Tumor Regression in BRAF-Mutant Melanoma
Roberto A. Salas Fragomeni et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma
Matteo S. Carlino et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Artemisinin-naphthoquine combination versus chloroquine-primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province, China
Hui Liu et al.
MALARIA JOURNAL (2013)
Nuclear export of proteins and drug resistance in cancer
Joel G. Turner et al.
BIOCHEMICAL PHARMACOLOGY (2012)
PKC and PKA Phosphorylation Affect the Subcellular Localization of Claudin-1 in Melanoma Cells
Amanda D. French et al.
International Journal of Medical Sciences (2012)
Inhibition of CRM1-Mediated Nucleocytoplasmic Transport: Triggering Human Melanoma Cell Apoptosis by Perturbing Multiple Cellular Pathways
Gaurav Pathria et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by NRAS or MEK Mutations
James G. Greger et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Importazole, a Small Molecule Inhibitor of the Transport Receptor Importin-β
Jonathan F. Soderholm et al.
ACS CHEMICAL BIOLOGY (2011)
Phosphorylation of β-catenin results in lack of β-catenin signaling in melanoma
Silke Kuphal et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Protein localization in disease and therapy
Mien-Chie Hung et al.
JOURNAL OF CELL SCIENCE (2011)
Identification of a Small Molecule Inhibitor of Importin β Mediated Nuclear Import by Confocal On-Bead Screening of Tagged One-Bead One-Compound Libraries
Martin Hintersteiner et al.
ACS CHEMICAL BIOLOGY (2010)
Cutaneous Malignant Melanoma Associated with Papillary Thyroid Cancer
Chi Yeon Kim et al.
ANNALS OF DERMATOLOGY (2010)
Small molecule peptidomimetic inhibitors of importin α/β mediated nuclear transport
Geza Ambrus et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Poly(ADP-Ribose) Polymerase-1 Is a Determining Factor in Crm1-Mediated Nuclear Export and Retention of p65 NF-κB upon TLR4 Stimulation
Mourad Zerfaoui et al.
JOURNAL OF IMMUNOLOGY (2010)
BRAF Mutation in Papillary Thyroid Carcinoma: Pathogenic Role and Clinical Implications
Kam-Tsun Tang et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2010)
Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 Inhibition
Joel G. Turner et al.
CANCER RESEARCH (2009)
Identification of Nuclear Export Inhibitors with Potent Anticancer Activity In vivo
Sarah C. Mutka et al.
CANCER RESEARCH (2009)
STRA8 Shuttles between Nucleus and Cytoplasm and Displays Transcriptional Activity
Marianna Tedesco et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Molecular markers of aggressiveness of thyroid cancer
Matthew D. Ringel
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2009)
WNT5A expression increases during melanoma progression and correlates with outcome
Philip D. Da Forno et al.
CLINICAL CANCER RESEARCH (2008)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital Melanocytic Nevi
Barbara Dessars et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility
P. D. Leotlela et al.
ONCOGENE (2007)
Structure-based design of a pathway-specific nuclear import inhibitor
Ahmet E. Cansizoglu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Minireview: AKT in thyroid tumorigenesis and progression
Motoo Shinohara et al.
ENDOCRINOLOGY (2007)
Human melanoma cells express functional receptors for thyroid-stimulating hormone
Julie A. Ellerhorst et al.
ENDOCRINE-RELATED CANCER (2006)
BCR-ABL nuclear entrapment kills human CMIL cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B
A Aloisi et al.
BLOOD (2006)
Nucleocytoplasmic shuttling of signal transducers
L Xu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Nuclear transport and cancer: From mechanism to intervention
TR Kau et al.
NATURE REVIEWS CANCER (2004)
Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs
Y Takenaka et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Multi parameter in vitro testing of ratjadone using flow cytometry
A Burzlaff et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2003)
Loss of beta-catenin expression in metastatic gastric cancer
MPA Ebert et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation
CL Brooks et al.
CURRENT OPINION IN CELL BIOLOGY (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Transport into and out of the nucleus
IG Macara
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2001)
Loss of β-catenin expression associated with disease progression in malignant melanoma
T Kageshita et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Cytoplasmic and nuclear accumulation of β-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma
K Omholt et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Regulation of p53 localization
SH Liang et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN
N Nakamura et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
RH Medema et al.
NATURE (2000)
Galectin-3 expression and subcellular localization in senescent human fibroblasts
KP Openo et al.
EXPERIMENTAL CELL RESEARCH (2000)
Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism
M Adachi et al.
JOURNAL OF CELL BIOLOGY (2000)
分享论文
